22-ene-25-oxavitamin D

Subscribe to Selected New Research on 22-ene-25-oxavitamin D

1 relevant articles (1 outcomes, 0 trials/studies) found for this Bio-Agent

Description: an immunosuppressive agent; structure in first source

Also Known As:

22-ene-25-oxa-vitamin D; ZK 156979; ZK-156979; ZK156979

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 58

Steroids: 13691

Secosteroids: 3

Vitamin D: 7152

22-ene-25-oxavitamin D: 1

Experts

1.	Steinmeyer, Andreas: 1 article (11/2006)
2.	Radeke, Heinfried H: 1 article (11/2006)
3.	Daniel, Carolin: 1 article (11/2006)
4.	Stein, Jürgen: 1 article (11/2006)
5.	Sartory, Nico A: 1 article (11/2006)
6.	Zuegel, Ulrich: 1 article (11/2006)
7.	Zahn, Nadine: 1 article (11/2006)

Related Diseases

1.	Colitis 11/01/2006 - "We found that treatment with ZK156979 clearly reduced the severity of TNBS-induced colitis without exhibiting calcemic effects" 11/01/2006 - "To conclude, our data provide the first clear evidence that ZK156979 exhibits a beneficial prophylactic as well as therapeutic profile in T helper cell type 1-like experimental colitis, offering new therapeutic options for the treatment of human inflammatory bowel diseases." 11/01/2006 - "The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice." 11/01/2006 - "Here, in vivo colitis was induced by applying a rectal enema of 2,4,6-trinitrobenzene sulfonic acid (TNBS) to male BALB/c mice, and calcitriol (0.2 microg/kg) or ZK156979 (0.1-2.0 microg/kg) was given i.p" Get all the results and reference details, order at left...
2.	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/01/2006 - "To conclude, our data provide the first clear evidence that ZK156979 exhibits a beneficial prophylactic as well as therapeutic profile in T helper cell type 1-like experimental colitis, offering new therapeutic options for the treatment of human inflammatory bowel diseases." Get all the results and reference details, order at left...
2 Diseases and 1 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Vitamin D
2.	Calcitriol (Calcijex)
3.	sym-trinitrobenzene
3 Drugs and Important Bio-Agents and 1 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Enema (Enemas)
1 Therapies and Procedures and 1 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>